Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tensha Therapeutics

Request full access

Small molecule selective bromodomain inhibitors for treating cancer and other diseases

Cambridge, United StatesFounded 2011Biotech & Life Sciences

About Tensha Therapeutics

Tensha Therapeutics is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in oncology and rare diseases. The company operates in the highly specialized field of drug development, targeting specific patient populations with limited treatment options. Tensha Therapeutics employs a business model centered around research and development (R&D), leveraging cutting-edge science to create novel therapeutic solutions. The company generates revenue through partnerships, licensing agreements, and eventual commercialization of its proprietary drugs. Tensha Therapeutics serves a global market, primarily collaborating with healthcare providers, research institutions, and pharmaceutical companies. By focusing on niche markets with high medical needs, the company aims to bring transformative treatments to patients, thereby improving their quality of life.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
1
Open positions
None listed
Dealroom signal
59.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Testing, Biotechnology, Oncology, Spinout, Biotech and Pharma, medical testing, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jan 2016 $535M $535M Roche —
EARLY VCEquity / VC Apr 2012 $0 — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Tensha Therapeutics website traffic

Latest recorded traffic for Tensha Therapeutics is 0 monthly website visits. Tensha Therapeutics's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
SyantraPrecision healthcare company that focuses on the commercialization of breast cancer detection blood tests Calgary, Canada Operational 16 $10M $14M
New Horizon HealthResearches and develops technology for early-stage cancer screening Hangzhou, China Operational
Metabolomic TechnologiesCommitted to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs Edmonton, Canada Operational
CARsgen TherapeuticsA leading immunotherapy company focused on the development of new chimeric antigen receptor Xuhui District, China Operational
BiolidicsA Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment Singapore, Singapore Operational
Singlera GenomicsA developer of 'liquid biopsy'​ analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA San Diego, United States Operational
CancerGuide DiagnosticsMolecular diagnostics company developing genomic-based clinical and pharmaceutical cancer tests and services Durham, United States Closed
CharlestonPharma,LLCCharlestonPharma is focused on developing innovative therapeutic antibodies and related diagnostic tests for cancer patients Charleston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tensha Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Tensha Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • HealthCare Ventures

Other known investors2 additional known investors

  • Dana-Farber Cancer Institute
  • Roche
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tensha Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tensha Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.